SANTE VERTE LIMITED

Figures converted to GBP from EUR at 0.870 per EUR (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  —

  Not reported

• Cash

  +2,061.2%

  £9,524 → £205,832

• Net assets

  -0.5%

  £11,130,063 → £11,079,378

• Employees

  0%

  3 → 3

• Operating profit

  +23.1%

  -£57,495 → -£44,213

• Profit before tax

  +6.9%

  -£54,439 → -£50,685

• Wages

  +59.1%

  £12,597 → £20,048

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Verallo

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Sante Verte Limited has made a loss for the year of €50,685 (2023: €54,439). The loss is supported by a strong net asset position of €11,079,378 at 31 December 2024 (2023 - €11,130,063). The company is also in a net current asset position of €455,139 (2023 - net current liabilities €172,513). Sante Verte Limited is reliant on support from its parent company, Laboratorios Cinfa, S.A. A letter of support has been obtained from Laboratorios Cinfa, S.A., which confirms that financial support will be provided for at least 12 months from the date of signing of these financial statements, to allow the company to meet its payment and business management commitments, as they fall due. The financial statements have been prepared on a going concern basis, however, as part of a potential group restructuring, it is probable that Sante Verte Limited, will be liquidated, within the next 12 months, subject to formal approval by the boards and shareholders. At the reporting date, no formal decision to liquidate the company had been made, and the company continues to operate as normal. The company continues to meet its obligations as they fall due, and has the ongoing support of the group. The anticipated liquidation is part of an internal reorganisation and is not expected to have a material adverse impact on stakeholders, as all liabilities are expected to be settled in full or transferred within the group. Management has assessed the company's ability to continue as a going concern and, based on current fact and circumstances, believe it remains appropriate to prepare the financial statements on a going concern basis. The possible future liquidation, presents a significant judgement and if approved, would require a change in the basis of preparation in future reporting periods.”

Group structure

1. SANTE VERTE LIMITED · parent
   1. Sante Verte SAS 100% · France · Natural health and beauty products

Significant events

• “as part of a potential group restructuring, it is probable that Sante Verte Limited, will be liquidated, within the next 12 months, subject to formal approval by the boards and shareholders.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

3

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.